Skip to main content
. 2021 Feb 16;22(4):1960. doi: 10.3390/ijms22041960

Figure 1.

Figure 1

Adverse drug reactions at different follow-up visits: percentage of the whole cohort experiencing each type of adverse drug reaction (ADR), 15 (T15d), 30 (T30d) and 60 days (T60d) after BZN treatment initialization, across the whole follow-up period. ADRs grouped as dermatological, digestive, neurological, and other less common manifestations.